BioPharm.Si (Q3270309): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item: Fix SL budget) |
||||||
Property / EU contribution | |||||||
4,777,897.3 Euro
| |||||||
Property / EU contribution: 4,777,897.3 Euro / rank | |||||||
Normal rank | |||||||
Property / budget | |||||||
5,972,371.63 Euro
| |||||||
Property / budget: 5,972,371.63 Euro / rank | |||||||
Normal rank | |||||||
Property / co-financing rate | |||||||
80.0 percent
| |||||||
Property / co-financing rate: 80.0 percent / rank | |||||||
Normal rank |
Revision as of 14:06, 7 February 2022
Project Q3270309 in Slovenia
Language | Label | Description | Also known as |
---|---|---|---|
English | BioPharm.Si |
Project Q3270309 in Slovenia |
Statements
4,777,897.3 Euro
0 references
5,972,371.63 Euro
0 references
80.0 percent
0 references
7 July 2016
0 references
31 December 2021
0 references
CO BIK
0 references
0 references
5270
0 references
Nova Generacija bioloških zdravil (Slovenian)
0 references
Identifiers
OP20.00363
0 references